A S X A N N O U N C E M E N T ASX: CUV | Nasdaq: CUVL | Börse Frankfurt: UR9 ASX Announcement PAGE 1 OF 2 CLINUVEL date of Annual General Meeting Melbourne / Singapore – 18 September 2026 – CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today provides notice that its Annual...
CLINUVEL date of Annual General Meeting
Filed with ASX · · 2 pages · English
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings CallRelease
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL develops proprietary ZEROKIN device
- Ceasing to be a substantial holder
- A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
- CLINUVEL considers Nasdaq listing, ASX delisting
- Appendix 4E and Annual Report to Shareholders 2026
Later from Clinuvel Pharmaceuticals
- Becoming a substantial holder
- New CUV105 vitiligo cases presented to EADV
- Notice of Annual General Meeting/Proxy Form
- Change in substantial holding
- Application for quotation of securities - CUV
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals